GENERAL (Narrative) (Details) € in Thousands, $ in Thousands |
1 Months Ended | ||
---|---|---|---|
Jul. 31, 2020
kg
|
Jan. 23, 2020
CAD ($)
|
Jan. 23, 2020
EUR (€)
|
|
Disclosure of subsidiaries [line items] | |||
Amounts to be delivered over the terms of several binding medical cannabis sales agreements | 1,525 | ||
I.M.C. Holdings Ltd [Member] | |||
Disclosure of subsidiaries [line items] | |||
Proportion of ownership interest in joint venture | 25.00% | ||
Investments in joint ventures | $ 2,189 | € 1,500 | |
Percentage of total production from Joint Venture at preferred price | 25.00% | ||
Galen Industries Single Member Societe Anonyme [Member] | |||
Disclosure of subsidiaries [line items] | |||
Proportion of ownership interest in joint venture | 75.00% | ||
Galen Industries Single Member Societe Anonyme [Member] | I.M.C. Holdings Ltd [Member] | |||
Disclosure of subsidiaries [line items] | |||
Commitments in relation to joint ventures | $ 11,675 | € 8,000 |
X | ||||||||||
- Definition The commitments that the entity has relating to its joint ventures as specified in paragraphs B18-B20 of IFRS 12. [Refer: Joint ventures [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes of the table. No definition available.
|
X | ||||||||||
- Definition The amount of investments in joint ventures in an entity's separate financial statements. [Refer: Joint ventures [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The proportion of ownership interest in a joint venture attributable to the entity. [Refer: Joint ventures [member]] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amounts to be delivered over the terms of several binding medical cannabis sales agreements. No definition available.
|
X | ||||||||||
- Definition Represents percentage of right to purchase of total production from the Joint Venture at a preferred price as determined in the agreement. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|